Pfizer wins first U.S. trial over Zoloft birth-defect risk

April 17 (Reuters) - Pfizer Inc was cleared of liability on Friday in the first of more than 1,000 U.S. lawsuits to go to trial alleging that its antidepressant Zoloft can cause birth defects, a company spokeswoman said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.